Showing results (1111-1120 of 5,723) with videos related to

Sort By:
Pageof 573
Medical Oncology (Northwood, London, England)|May 13, 2014
COX2 expression in high-grade breast cancer: evidence for prognostic significance in the subset of triple-negative breast cancer patientsBar Chikman, Sergey Vasyanovich, Ron Lavy, et al.
Medical Oncology (Northwood, London, England)|May 13, 2014
Variation in N-acetyltransferase 2 (NAT2), smoking and risk of prostate cancer in the Slovak populationMarta Vilčková, Jana Jurečeková, Dušan Dobrota, et al.
Medical Oncology (Northwood, London, England)|March 29, 2019
Neck management in head and neck squamous cell carcinomas: where do we stand?Guillaume Klausner, Idriss Troussier, Eivind Blais, et al.
Medical Oncology (Northwood, London, England)|March 15, 2021
An updated review of epidemiology, risk factors, and management of male breast cancerNoman Ahmed Jang Khan, Maria Tirona
Medical Oncology (Northwood, London, England)|November 8, 2021
The role of inflammatory indices in the outcome of COVID-19 cancer patientsHend A Nooh, Mona S Abdellateif, Lobna Refaat, et al.
Medical Oncology (Northwood, London, England)|January 2, 2014
Vitamin D receptor gene polymorphisms and esophageal cancer risk in a Chinese population: a negative studyHaiyong Gu, Xu Wang, Liang Zheng, et al.
Medical Oncology (Northwood, London, England)|May 28, 2014
Mutations of KRAS and PIK3CA as independent predictors of distant metastases in colorectal cancerKunli Zhu, Hongjiang Yan, Renben Wang, et al.
Medical Oncology (Northwood, London, England)|January 29, 2014
HBsAg is an independent prognostic factor in diffuse large B cell lymphoma patients in rituximab era: result from a multicenter retrospective analysis in ChinaZheng Wei, Shanhua Zou, Feng Li, et al.
Medical Oncology (Northwood, London, England)|January 29, 2014
Reduced ABCG2 and increased SLC22A1 mRNA expression are associated with imatinib response in chronic myeloid leukemiaLuciene Terezina de Lima, Douglas Vivona, Carolina Tosin Bueno, et al.
Medical Oncology (Northwood, London, England)|June 29, 2014
Overexpression of interleukin-8 receptor 2 (IL-8R2) indicates better prognosis in esophageal adenocarcinoma and squamous cell carcinoma processionBing Liang, Hui Zhao, Jian-Bo Che, et al.
Pageof 573